Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2012
08/01/2012CN102614527A Antiacid nano oral deoxyribonucleic acid (DNA) anti-tumor vaccine with potential of hydrogen (pH) sensitive characteristic and preparation method
08/01/2012CN102614524A Brain tumour targeting gene delivery composite modified by low density lipoprotein receptor associated protein ligand polypeptide
08/01/2012CN102614522A Preparation of dendrimer-modified multi-walled carbon nanotube type composite material-loaded adriamycin
08/01/2012CN102614521A Treatment methods utilizing albumin-binding proteins as targets
08/01/2012CN102614515A Novel chemical restructuring high-density lipoprotein drug carrying system with targeted and double anti-tumor effects and application
08/01/2012CN102614512A Multiple-variable dose regimen for treating TNFalpha-related disorders
08/01/2012CN102614506A Recombinant HPV16L2 protein vaccine and preparation method thereof
08/01/2012CN102614505A Chimeric protein vaccine containing HPV16 type L1 and E7 target antigens expressed in yeast cells and its preparation method
08/01/2012CN102614497A Usage of human interferon in preparation of medicines for treatment or prevention of HPV (human paillomavirus) related diseases
08/01/2012CN102614495A Application of Escherichia coli BL21 ribosomal protein subunit L36 in preparing anticancer drugs
08/01/2012CN102614473A Chinese medicinal compound preparation for treating malignant solid tumor
08/01/2012CN102614471A Traditional Chinese medicine for treating breast carcinoma
08/01/2012CN102614466A Traditional Chinese medical preparation for treatment of lung adenocarcinoma
08/01/2012CN102614365A Traditional Chinese medical composition for treatment of breast tumor
08/01/2012CN102614354A Anticancer oral liquid and preparation method thereof
08/01/2012CN102614353A Saponin extraction process by using star-of-bethlehem ultrafiltration separation method
08/01/2012CN102614308A Method for extracting bioactivator in hot chili residue through subcritical water
08/01/2012CN102614302A Chinese medicine for treating carcinous pain
08/01/2012CN102614299A Traditional Chinese medicine for curing cancer pain
08/01/2012CN102614284A Oral liquid for treating malignancy and preparing method
08/01/2012CN102614268A Chinese medicine for treating esophageal carcinoma
08/01/2012CN102614254A Method for extracting roots of red-rooted salvia
08/01/2012CN102614251A Traditional Chinese medicinal preparation for treating cancers
08/01/2012CN102614238A Application of lucide ganoderma and ginseng medicinal mycoplasm in preparing drugs for treating lung cancer
08/01/2012CN102614228A Application of pine needle fat-soluble extract to preparation of tumor treating medicament
08/01/2012CN102614227A Ganoderma pill and processing method thereof
08/01/2012CN102614226A Application of cordyceps militaris link extract to preparation of health-care product or medicament for prompting leucocyte proliferation of breast cancer patient
08/01/2012CN102614223A Drug for treating lung cancer
08/01/2012CN102614209A Application of compound echinoside A in preparation of medicines for treating glioma
08/01/2012CN102614208A Application of compound (20R,24R)-24,25-16,23-23,27-triepoxy-12-acetoxyl-9,19-cyclolanostanol-3-O-beta-D xylopyranoside in pharmacy
08/01/2012CN102614202A Mixture and liquid medicine or oral liquid for injection
08/01/2012CN102614201A Combretastain diphosphate tetrasodium composition for injection and preparation method thereof
08/01/2012CN102614200A Application of (4-substituted benzoyl) fluorobenzene salicylamide compound in preparation of medicine for resisting breast cancer
08/01/2012CN102614199A Application of (4-substituted benzoyl) fluorobenzene salicylamide compound in preparation of medicine for resisting cervical cancer
08/01/2012CN102614198A Application of (4-substituted benzene formyl) fluorobenzene salicylamide compound in preparation of anti-lung-cancer medicines
08/01/2012CN102614197A Application of phenylacetyl fluorobenzene salicylamide compound in preparation of anti-cervical-cancer medicines
08/01/2012CN102614196A Application of phenylacetyl fluorobenzene salicylamide compound in preparation of anti-breast-cancer medicines
08/01/2012CN102614195A Triterpenoid composition of antrodia cinnamomea, preparation and analysis method thereof
08/01/2012CN102614191A Synthesis of thiacalixarene metal coordination compound and application of thiacalixarene metal coordination compound serving as anti-cancer medicine
08/01/2012CN102614183A Oral preparation containing tegafur, gimeracil and oteracil potassium
08/01/2012CN102614180A Use of itraconazole in preparation of drug for treating multiple myeloma
08/01/2012CN102614170A Application of artemisinin B in preparation of antitumor drugs
08/01/2012CN102614169A Compound pharmaceutical composition for improving oral bioavailability of paclitaxel and application thereof
08/01/2012CN102614168A Artemisinin detrivative and application of its medicinal salt
08/01/2012CN102614165A Use of substituted benzoates (besilates) as selective ligands of estrogen acceptor
08/01/2012CN102614162A Application of gingerol and cerous oxalate composition to preparation of toxicity-decreasing and efficacy-increasing drugs for cancer chemotherapy
08/01/2012CN102614158A Emodin derivative with antitumor activity and preparation method thereof
08/01/2012CN102614137A Gemcitabine hydrochloride freeze-dried powder injection and preparation method thereof
08/01/2012CN102614127A Resveratrol nanoscale dispersoid and preparation method thereof
08/01/2012CN102614126A Thermosensitive liposome and its application
08/01/2012CN102614125A SapC-phosphatide nano vesicle freezed-drying preparation, and preparation method and application thereof
08/01/2012CN102614118A Preparation method for epirubicin hydrochloride preparation for injection and preparation
08/01/2012CN102614117A Decitabine liquid composition and preparation method of its lyophilized preparation
08/01/2012CN102614110A Stable polyethylene glycol medicinal micelle composition and preparation method thereof
08/01/2012CN102614105A Brain targeted amphotericin B (AmB) polymer micelle administration system
08/01/2012CN102613356A Aquilaria agallocha leaf tea, as well as preparation and application thereof
08/01/2012CN102160863B Purification preparation method of isoalantolactone and application of isoalantolactone in preparation of anti-tumor drugs
08/01/2012CN102144969B Method for preparing etoposide nanometer suspension freeze-drying preparation
08/01/2012CN102008443B 4-amino-2-trifluoromethyl-phenylretinate solid dispersion and preparation method thereof
08/01/2012CN101381320B Compounds with mannich base structure and application thereof in preparation of medicament treating and/or preventing leukemia
07/2012
07/31/2012US8232383 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
07/31/2012US8232318 Approaches to treat cancer using HB-EGF inhibitors
07/31/2012US8232283 Raf inhibitors
07/31/2012US8232260 In vivo production of small interfering RNAs that mediate gene silencing
07/31/2012US8232252 Immunoglobulin/bone morphogenic protein fusion for treatment and prevention of inflammatory disorders
07/31/2012US8232068 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
07/31/2012CA2528323C 2-hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide
07/31/2012CA2528322C 2-hydroxymethyl-3,4,5-trihydroxy-1-(4-pentlyoxybenzyl) piperidine as glucosylceramide synthase (gcs)
07/31/2012CA2489965C Pharmaceutical compositions for the treatment of diseases related to neurotrophines
07/31/2012CA2478409C Inhibitors of urokinase, their preparation and use
07/31/2012CA2465375C 2-aryl-propionic acids and pharmaceutical compositions containing them
07/31/2012CA2349217C Cancer-associated antigens and methods of their identification
07/31/2012CA2348624C Adenovirus-mediated gene therapy
07/26/2012WO2012100135A1 Picolinamide inhibitors of kinases
07/26/2012WO2012100045A2 Methods of predicting response to jnk inhibitor therapy
07/26/2012WO2012099968A1 Compositions and methods for treating skin cancer associated diseases
07/26/2012WO2012099916A1 Quinazolinone inhibitors of dynein
07/26/2012WO2012099581A1 Dihydrofuropyrimidine compounds
07/26/2012WO2012099454A1 Curcumin compounds and their preparations thereof
07/26/2012WO2012099451A1 Curcumin compounds containing indolizine and their preparations thereof
07/26/2012WO2012099424A2 Composition and functional health food comprising fenugreek extracts for treating brain cancer
07/26/2012WO2012099422A2 Composition and functional health food comprising lysimachiae foenum-graeci herba extracts for treating brain cancer
07/26/2012WO2012099420A2 Composition and functional health food comprising elecampane extracts for treating brain cancer
07/26/2012WO2012099419A2 Composition and functional health food comprising cirsium japonicum extracts for treating brain cancer
07/26/2012WO2012099129A1 Compound having anti-cancer activity
07/26/2012WO2012099093A1 Process for production of nk-cell-enriched blood preparation
07/26/2012WO2012098692A1 Composition for inhibiting target gene expression
07/26/2012WO2012098557A1 Pegylated gemcitabine derivative and process for preparing the same
07/26/2012WO2012098397A1 Combination therapy for cancer
07/26/2012WO2012098387A1 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors
07/26/2012WO2012098237A1 Compounds with super-aspirin effects
07/26/2012WO2012098234A1 Biologically active nucleotide molecules for selectively killing off cells, use thereof, and application kit
07/26/2012WO2012098222A1 Bisphosphonate-polyaspartamide conjugates as polymeric carriers for drug targeting to bones
07/26/2012WO2012098132A1 Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer
07/26/2012WO2012098070A1 Quinoline dyrk1 inhibitors
07/26/2012WO2012098068A1 Pyrazolo pyrimidines as dyrk1a and dyrk1b inhibitors
07/26/2012WO2012098066A1 1,6- and 1,8-naphthyridines useful as dyrk1 inhibitors
07/26/2012WO2012098065A1 Pyrido pyrimidines for use as dyrk1 inhibitors
07/26/2012WO2012097684A1 Bicyclic carboxamide inhibitors of kinases
07/26/2012WO2012097683A1 Bicyclic inhibitors of alk
1 ... 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 ... 2211